 | • レポートコード：D005-10842 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、mRNAワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。mRNAワクチンの種類別市場規模（がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別市場規模（感染症、がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Moderna Therapeutics、eTheRNA、BioNTech、CureVac、In-Cell-Art、Translate Bio、Tiba Biotechnology、Argos Therapeutics、Sangamo Therapeutics、Ethris ・地域別グローバル市場分析 2015年-2020年 ・mRNAワクチンの北米市場（アメリカ、カナダ、メキシコ） ・mRNAワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・mRNAワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・mRNAワクチンの南米市場（ブラジル、アルゼンチン） ・mRNAワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：がん治療標準化MRNAワクチン、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン ・用途別分析：感染症、がん、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global mRNA Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The mRNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
mRNA Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, mRNA Vaccine market has been segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Application, mRNA Vaccine has been segmented into:
Infectious Disease
Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the mRNA Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and mRNA Vaccine Market Share Analysis
mRNA Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, mRNA Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in mRNA Vaccine are:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Among other players domestic and global, mRNA Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of mRNA Vaccine, with price, sales, revenue and global market share of mRNA Vaccine in 2018 and 2019.
Chapter 3, the mRNA Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, mRNA Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe mRNA Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 mRNA Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mRNA Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global mRNA Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Overview of Global mRNA Vaccine Market
1.4.1 Global mRNA Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Translate Bio SWOT Analysis
2.6.4 Translate Bio Product and Services
2.6.5 Translate Bio mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Tiba Biotechnology SWOT Analysis
2.7.4 Tiba Biotechnology Product and Services
2.7.5 Tiba Biotechnology mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Argos Therapeutics SWOT Analysis
2.8.4 Argos Therapeutics Product and Services
2.8.5 Argos Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sangamo Therapeutics SWOT Analysis
2.9.4 Sangamo Therapeutics Product and Services
2.9.5 Sangamo Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ethris SWOT Analysis
2.10.4 Ethris Product and Services
2.10.5 Ethris mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global mRNA Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global mRNA Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 mRNA Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 mRNA Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global mRNA Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global mRNA Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America mRNA Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe mRNA Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Vaccine Sales and Growth Rate (2015-2020)
4.5 South America mRNA Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa mRNA Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America mRNA Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America mRNA Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America mRNA Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States mRNA Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada mRNA Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico mRNA Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe mRNA Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe mRNA Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe mRNA Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany mRNA Vaccine Sales and Growth Rate (2015-2020)
6.3 UK mRNA Vaccine Sales and Growth Rate (2015-2020)
6.4 France mRNA Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia mRNA Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy mRNA Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific mRNA Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific mRNA Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific mRNA Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China mRNA Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan mRNA Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea mRNA Vaccine Sales and Growth Rate (2015-2020)
7.5 India mRNA Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia mRNA Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America mRNA Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America mRNA Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America mRNA Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil mRNA Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina mRNA Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa mRNA Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa mRNA Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa mRNA Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia mRNA Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey mRNA Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt mRNA Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa mRNA Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global mRNA Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global mRNA Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global mRNA Vaccine Price by Type (2015-2020)
11 Global mRNA Vaccine Market Segment by Application
11.1 Global mRNA Vaccine Sales Market Share by Application (2015-2020)
11.2 Global mRNA Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global mRNA Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global mRNA Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 mRNA Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America mRNA Vaccine Market Forecast (2021-2025)
12.2.2 Europe mRNA Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific mRNA Vaccine Market Forecast (2021-2025)
12.2.4 South America mRNA Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa mRNA Vaccine Market Forecast (2021-2025)
12.3 mRNA Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global mRNA Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global mRNA Vaccine Market Share Forecast by Type (2021-2025)
12.4 mRNA Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global mRNA Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global mRNA Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global mRNA Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. Moderna Therapeutics mRNA Vaccine Major Business
Table 9. Moderna Therapeutics mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Moderna Therapeutics SWOT Analysis
Table 11. Moderna Therapeutics mRNA Vaccine Product and Services
Table 12. Moderna Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 14. eTheRNA mRNA Vaccine Major Business
Table 15. eTheRNA mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. eTheRNA SWOT Analysis
Table 17. eTheRNA mRNA Vaccine Product and Services
Table 18. eTheRNA mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. BioNTech Basic Information, Manufacturing Base and Competitors
Table 20. BioNTech mRNA Vaccine Major Business
Table 21. BioNTech mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. BioNTech SWOT Analysis
Table 23. BioNTech mRNA Vaccine Product and Services
Table 24. BioNTech mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. CureVac Basic Information, Manufacturing Base and Competitors
Table 26. CureVac mRNA Vaccine Major Business
Table 27. CureVac mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. CureVac SWOT Analysis
Table 29. CureVac mRNA Vaccine Product and Services
Table 30. CureVac mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 32. In-Cell-Art mRNA Vaccine Major Business
Table 33. In-Cell-Art mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. In-Cell-Art SWOT Analysis
Table 35. In-Cell-Art mRNA Vaccine Product and Services
Table 36. In-Cell-Art mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 38. Translate Bio mRNA Vaccine Major Business
Table 39. Translate Bio mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 40. Translate Bio SWOT Analysis
Table 41. Translate Bio mRNA Vaccine Product and Services
Table 42. Translate Bio mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Tiba Biotechnology mRNA Vaccine Major Business
Table 45. Tiba Biotechnology mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 46. Tiba Biotechnology SWOT Analysis
Table 47. Tiba Biotechnology mRNA Vaccine Product and Services
Table 48. Tiba Biotechnology mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 50. Argos Therapeutics mRNA Vaccine Major Business
Table 51. Argos Therapeutics mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 52. Argos Therapeutics SWOT Analysis
Table 53. Argos Therapeutics mRNA Vaccine Product and Services
Table 54. Argos Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 56. Sangamo Therapeutics mRNA Vaccine Major Business
Table 57. Sangamo Therapeutics mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 58. Sangamo Therapeutics SWOT Analysis
Table 59. Sangamo Therapeutics mRNA Vaccine Product and Services
Table 60. Sangamo Therapeutics mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ethris Basic Information, Manufacturing Base and Competitors
Table 62. Ethris mRNA Vaccine Major Business
Table 63. Ethris mRNA Vaccine Total Revenue (USD Million) (2017-2018)
Table 64. Ethris SWOT Analysis
Table 65. Ethris mRNA Vaccine Product and Services
Table 66. Ethris mRNA Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global mRNA Vaccine Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global mRNA Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global mRNA Vaccine Sales by Regions (2015-2020) (K Doses)
Table 70. Global mRNA Vaccine Sales Market Share by Regions (2015-2020)
Table 71. Global mRNA Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 72. North America mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 73. North America mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 74. North America mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 75. North America mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 76. Europe mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 77. Europe mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 78. Europe mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific mRNA Vaccine Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific mRNA Vaccine Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific mRNA Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 82. South America mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 83. South America mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 84. South America mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 85. South America mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa mRNA Vaccine Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa mRNA Vaccine Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa mRNA Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global mRNA Vaccine Sales by Type (2015-2020) (K Doses)
Table 91. Global mRNA Vaccine Sales Share by Type (2015-2020)
Table 92. Global mRNA Vaccine Revenue by Type (2015-2020) (USD Million)
Table 93. Global mRNA Vaccine Revenue Share by Type (2015-2020)
Table 94. Global mRNA Vaccine Sales by Application (2015-2020) (K Doses)
Table 95. Global mRNA Vaccine Sales Share by Application (2015-2020)
Table 96. Global mRNA Vaccine Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global mRNA Vaccine Market Share Forecast by Regions (2021-2025)
Table 98. Global mRNA Vaccine Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global mRNA Vaccine Market Share Forecast by Type (2021-2025)
Table 100. Global mRNA Vaccine Sales Forecast by Application (2021-2025)
Table 101. Global mRNA Vaccine Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. mRNA Vaccine Picture
Figure 2. Global Sales Market Share of mRNA Vaccine by Type in 2019
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Picture
Figure 6. Infection Prevention MRNA Vaccine Picture
Figure 7. mRNA Vaccine Sales Market Share by Application in 2018
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global mRNA Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey mRNA Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global mRNA Vaccine Sales Market Share by Manufacturer in 2019
Figure 32. Global mRNA Vaccine Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 mRNA Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 mRNA Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 37. Global mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global mRNA Vaccine Revenue Market Share by Regions (2015-2020)
Figure 39. Global mRNA Vaccine Revenue Market Share by Regions in 2018
Figure 40. North America mRNA Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Europe mRNA Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific mRNA Vaccine Sales and Growth Rate (2015-2020)
Figure 43. South America mRNA Vaccine Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa mRNA Vaccine Sales and Growth Rate (2015-2020)
Figure 45. North America mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America mRNA Vaccine Sales Market Share by Countries (2015-2020)
Figure 47. North America mRNA Vaccine Sales Market Share by Countries in 2018
Figure 48. North America mRNA Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America mRNA Vaccine Revenue Market Share by Countries in 2018
Figure 50. United States mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Canada mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Mexico mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 53. Europe mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. Europe mRNA Vaccine Revenue Market Share by Countries in 2019
Figure 56. Germany mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. UK mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. France mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Russia mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Italy mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. Asia-Pacific mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific mRNA Vaccine Sales Market Share by Regions 2019
Figure 63. Asia-Pacific mRNA Vaccine Revenue Market Share by Regions 2019
Figure 64. China mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Japan mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. Korea mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. India mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Southeast Asia mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. South America mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America mRNA Vaccine Sales Market Share by Countries in 2019
Figure 71. South America mRNA Vaccine Revenue Market Share by Countries in 2019
Figure 72. Brazil mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Argentina mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 74. Middle East and Africa mRNA Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa mRNA Vaccine Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa mRNA Vaccine Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa mRNA Vaccine Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Egypt mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. Turkey mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. South Africa mRNA Vaccine Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Global mRNA Vaccine Sales and Growth Rate (2021-2025) (K Doses)
Figure 83. Global mRNA Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales mRNA Vaccine Market Forecast (2021-2025) (K Doses)
Figure 85. Europe Sales mRNA Vaccine Market Forecast (2021-2025) (K Doses)
Figure 86. Asia-Pacific Sales mRNA Vaccine Market Forecast (2021-2025) (K Doses)
Figure 87. South America Sales mRNA Vaccine Market Forecast (2021-2025) (K Doses)
Figure 88. Middle East & Africa Sales mRNA Vaccine Market Forecast (2021-2025) (K Doses)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
ライム病ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyme Disease Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyme Disease Vaccine mar…- 病気管理＆予防ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Disease Control and Prevention Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.6% in the forecast period of 2020 to 2025 and will expected to reach USD 55270 million by 2025, from USD 42850 million in 2019. The…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measle Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measle Vaccine market report p…
- 肺炎球菌ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pneumococcal Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.1% in the forecast period of 2020 to 2025 and will expected to reach USD 7551.8 million by 2025, from USD 7242 million in 2019. The Pneumococ…
- 樹状細胞がんワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dendritic Cell Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dendritic Cell …